Home » Myriad's myRisk Hereditary Cancer Test Improves Colon Cancer Testing By 60 Percent
Myriad's myRisk Hereditary Cancer Test Improves Colon Cancer Testing By 60 Percent
Myriad Genetics announced new clinical data from a study with myRisk Hereditary Cancer, a 25-gene hereditary cancer panel, that showed a 60 percent increase in mutations detected in cancer predisposition genes in patients with a prior history of colon cancer and/or polyps.
FirstWord MedTech
FirstWord MedTech
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May